v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Operating activities    
Net income $ 94,678 $ 61,083
Adjustments to reconcile net income to cash used in operating activities:    
Depreciation and amortization 44,307 41,635
Bad debt expense 198 700
Cash distributions in excess of (less than) income of unconsolidated affiliates, net of noncontrolling interests 8,643 (22,334)
Gain on sale of investments in affiliates (17,055) 0
Gains on sales of railcars and related leases (14,666) (17,376)
Excess tax benefit from share-based payment arrangement (1,770) (602)
Deferred income taxes 9,441 24,185
Stock-based compensation expense 7,542 2,337
Other (446) (149)
Changes in operating assets and liabilities:    
Accounts receivable 10,161 29,468
Inventories 218,460 348,172
Commodity derivatives 127,655 63,074
Other assets 11,755 (263)
Accounts payable for grain (370,005) (341,078)
Other accounts payable and accrued expenses (26,624) (59,891)
Net cash provided by operating activities 102,274 128,961
Investing Activities    
Acquisition of businesses, net of cash acquired 0 (11,148)
Purchases of railcars (39,294) (71,554)
Proceeds from sale of railcars 30,894 87,620
Purchases of property, plant and equipment (39,624) (31,355)
Proceeds from sale of property, plant and equipment 1,043 351
Proceeds from returns of investments in affiliates, net of noncontrolling interests 35,920 0
Investments in affiliates (238) (49,249)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (1,494) 0
Change in restricted cash 235 233
Net cash used in investing activities (12,558) (75,102)
Financing Activities    
Net change in short-term borrowings 0 (24,219)
Proceeds from issuance of long-term debt 1,787 53,794
Payments of long-term debt (64,442) (80,473)
Proceeds from sale of treasury shares to employees and directors 1,564 1,687
Payments of debt issuance costs (3,175) (46)
Dividends paid (9,359) (8,981)
Excess tax benefit from share-based payment arrangement 1,770 602
Net cash used in financing activities (71,855) (57,636)
Increase (decrease) in cash and cash equivalents 17,861 (3,777)
Cash and cash equivalents at beginning of period 309,085 138,218
Cash and cash equivalents at end of period 326,946 134,441
Supplemental disclosure of cash flow information    
Capital project costs incurred but not yet paid 5,502 5,477
Purchase of capitalized software through seller-financing $ 5,055 $ 10,477